Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

医学 肝细胞癌 外科肿瘤学 内科学 单变量分析 外科 肝硬化 阶段(地层学) 肝癌 多元分析 生物 古生物学
作者
Lan‐Qing Yao,Zhengliang Chen,Zihan Feng,Yong‐Kang Diao,Chao Li,Haiying Sun,Jian‐Hong Zhong,Ting‐Hao Chen,Wei‐Min Gu,Ya-Hao Zhou,Wanguang Zhang,Hong Zhang,Yongyi Zeng,Han Wu,Ming-Da Wang,Xin‐Fei Xu,Timothy M. Pawlik,Wan Yee Lau,Feng Shen,Tian Yang
出处
期刊:Annals of Surgical Oncology [Springer Science+Business Media]
卷期号:29 (7): 4291-4303 被引量:57
标识
DOI:10.1245/s10434-022-11454-y
摘要

BackgroundA potentially curative hepatic resection is the optimal treatment for hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur after resection. This study investigates clinical features of initial recurrence and long-term prognosis of patients with recurrence after curative resection for early-stage HCC.Patients and MethodsFrom a multicenter database, patients who underwent curative hepatic resection for early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0/A] were extracted. Time to initial recurrence, patterns of initial recurrence, and treatment modalities for recurrent tumors were investigated. Univariate and multivariate analysis were used to identify independent risks associated with postoperative recurrence, as well as post-recurrence survival (PRS) for patients with recurrence.ResultsAmong 1424 patients, 679 (47.7%) developed recurrence at a median follow-up of 54.8 months, including 408 (60.1%) early recurrence (≤ 2 years after surgery) and 271 (39.9%) late recurrence (> 2 years). Independent risks of postoperative recurrence included cirrhosis, preoperative alpha-fetoprotein level > 400 ug/L, tumor size > 5 cm, multiple tumors, satellites, microvascular invasion, and intraoperative blood transfusion. Multivariate analysis revealed that receiving irregular recurrence surveillance, initial tumor beyond Milan criteria, early recurrence, BCLC stage B/C of the recurrent tumor, and noncurative treatments were independently associated with poorer PRS.ConclusionsNearly half of patients with early-stage HCC experienced recurrence after resection. Understanding recurrence risks may help identify patients at high risk of recurrence who may benefit from future adjuvant therapies. Meaningful survival even after recurrence can still be achieved by postoperative regular surveillance and curative treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyw完成签到 ,获得积分10
刚刚
無羁完成签到,获得积分10
1秒前
orixero应助WJing采纳,获得10
1秒前
奋斗雁山完成签到,获得积分10
1秒前
JACK完成签到,获得积分10
2秒前
DASDSADASDA完成签到,获得积分10
3秒前
jincen发布了新的文献求助10
3秒前
Liufgui应助梁云采纳,获得20
3秒前
soso发布了新的文献求助10
3秒前
小西发布了新的文献求助10
3秒前
CHANYEOL发布了新的文献求助10
3秒前
3秒前
4秒前
majiko发布了新的文献求助10
4秒前
winstar发布了新的文献求助10
5秒前
6秒前
fcyyc发布了新的文献求助10
6秒前
6秒前
zhangpeiyu发布了新的文献求助10
6秒前
7秒前
7秒前
纣王完成签到,获得积分10
7秒前
8秒前
白飞应助LELE采纳,获得20
8秒前
贰鸟应助张二十八采纳,获得10
8秒前
8秒前
奶冻发布了新的文献求助10
10秒前
SciGPT应助kehaoran采纳,获得10
10秒前
合适绮波发布了新的文献求助10
11秒前
Akim应助别太拗口哦oo采纳,获得10
12秒前
桐桐应助Vincent1990采纳,获得10
12秒前
科研通AI2S应助悦耳怜珊采纳,获得10
13秒前
sonicgoboy发布了新的文献求助30
13秒前
13秒前
清爽莫言完成签到,获得积分10
13秒前
88888888888发布了新的文献求助10
13秒前
共享精神应助江湖夜雨采纳,获得10
14秒前
14秒前
14秒前
dabriaolga完成签到,获得积分10
14秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
徐淮辽南地区新元古代叠层石及生物地层 2000
A new approach to the extrapolation of accelerated life test data 1000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 400
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4025131
求助须知:如何正确求助?哪些是违规求助? 3564938
关于积分的说明 11347620
捐赠科研通 3296101
什么是DOI,文献DOI怎么找? 1815432
邀请新用户注册赠送积分活动 890060
科研通“疑难数据库(出版商)”最低求助积分说明 813229